FIELD: medicine.
SUBSTANCE: invention refers to medicine. Presented is a method for detecting p.Q368X (c.1102C>T) MYOC gene mutation accompanied by a congenital form of primary open-angle glaucoma (POAG). The DNA is recovered from peripheral blood lymphocytes by phenol-chloroform extraction, and a real-time polymerase chain reaction is performed and followed by determining an end-point maximum melting curve. The MYOC gene region is amplified in the presence of two oligonucleotide sequences with EvaGreen dye.
EFFECT: invention provides the effective diagnosis of POAG in patients of hereditary tainted families.
1 dwg, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING THE RISK OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA USING DATA ON CDKN2B-AS1 GENE POLYMORPHISM | 2021 |
|
RU2771137C1 |
METHOD FOR REVEALING c-53-2A>G MUTATION IN PRESTIN GENE (SLC26A5) CAUSING DEVELOPMENT OF NON-SYNDROME-BASED AUTSOMAL-RECESSIVE DEAFNESS | 2012 |
|
RU2505608C1 |
METHOD FOR PREDICTING THE RISK OF PRIMARY OPEN-ANGLE GLAUCOMA BASED ON THE DATA ON POLYMORPHIC VARIANTS OF THE LYSYL OXIDASE-LIKE ENZYME 1 GENE | 2021 |
|
RU2784769C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA IN WOMEN | 2021 |
|
RU2775431C1 |
METHOD OF DETECTING MUTATIONS IN GENE MYO7A, ACCOMPANIED BY DEVELOPMENT OF NON-SYNDROMIC AUTOSOMAL RECESSIVE DEAFNESS AND USHER SYNDROME | 2013 |
|
RU2555755C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING INITIAL OPEN-ANGLE GLAUCOMA WITHOUT EXFOLIATION SYNDROME USING DATA ON POLYMORPHISM OF MATRIX METAL PROTEINASE GENES | 2021 |
|
RU2760958C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA WITHOUT EXFOLIATION SYNDROME | 2022 |
|
RU2790757C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA IN MEN BASED ON GENETIC DATA | 2021 |
|
RU2775430C1 |
METHOD FOR PREDICTION OF TIMOLOL TREATMENT EFFECTIVENESS OF PRIMARY OPEN-ANGLE GLAUCOMA | 2018 |
|
RU2694744C1 |
METHOD FOR PREDICTING RISK OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA WITH EXFOLIATIVE SYNDROME BASED ON MOLECULAR GENETIC DATA | 2021 |
|
RU2753268C1 |
Authors
Dates
2016-04-27—Published
2014-02-27—Filed